Metraipolis › archive › dc_dd08bec7e8db

Strategic and Chemical Advances in Antibody-Drug Conjugates — Europe PMC PMID:41012501

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41012501
DOI: 10.3390/pharmaceutics17091164
License (as archived): solo-consultazione
Archived: 2026-11-10T02:44:51.786Z
SHA-256 of the archived text: 062ab629f5b5654eb738a096753e52e15d5857efefc76b97ae85cba34d9e45ae
Stable URL of this page: https://metraipolis.com/documento/dc_dd08bec7e8db

How to cite

Strategic and Chemical Advances in Antibody-Drug Conjugates — Europe PMC PMID:41012501 — Europe PMC (en), https://europepmc.org/article/MED/41012501 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dd08bec7e8db (Metraipolis archive dc_dd08bec7e8db, sha256 062ab629f5b5654eb738a096753e52e15d5857efefc76b97ae85cba34d9e45ae)

BibTeX

@misc{dcdd08bec7e8db,
  title = {Strategic and Chemical Advances in Antibody-Drug Conjugates — Europe PMC PMID:41012501},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41012501},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dd08bec7e8db; sha256 062ab629f5b5654eb738a096753e52e15d5857efefc76b97ae85cba34d9e45ae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012501. Agents can read the archived copy with the MCP tool read_document.